South Africa asks Serum Institute to take back 1 million vaccine doses, says report
South Africa has asked the Serum Institute of India to take back the one million COVID-19vaccine doses the company had s...
Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of ₹600 per dose and at ₹400 for state governments and any new contract by the central governmentThe Serum Institute of India (SII) today issued a clarification on the pricing of the covid-19 vaccine Covishield. SII said that the initial prices of the COVID-19 vaccine were low globally due to advance funding but it will need investment in scaling up the vaccine production now.Serum Institute of India, which makes the most used Covid-19 vaccine in the country, defended pricing Covishield vaccine at 1.5 times the initial rate."Only a limited portion of SII's volume will be sold to private at Rs600 per dose. The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat covid-19 and other life-threatening diseases," according to a statement from the SII.
View SourceThis notice has been removed
The content is no longer available
Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of ₹600 per dose and at ₹400 for state governments and any new contract by the central governmentThe Serum Institute of India (SII) today issued a clarification on the pricing of the covid-19 vaccine Covishield. SII said that the initial prices of the COVID-19 vaccine were low globally due to advance funding but it will need investment in scaling up the vaccine production now.Serum Institute of India, which makes the most used Covid-19 vaccine in the country, defended pricing Covishield vaccine at 1.5 times the initial rate."Only a limited portion of SII's volume will be sold to private at Rs600 per dose. The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat covid-19 and other life-threatening diseases," according to a statement from the SII.
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Sign in to continue to Global Noticeboard
Enter your email to receive a reset link
Create a new password for your account
You are marking this Notice are inappropriate, and you belive it infringes on the Global Noticeboard Community Guidelines (link). Is this so?
Create 3 Noticeboards to earn this Silver level Community Champion Badge.
View all badges that you can earnPlease tell us why you are reporting this content.
Discussion (0)
No comments yet